FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cefoxitin for Injection, USP
Status: Currently in Shortage
»Date first posted: 05/03/2019
»Therapeutic Categories: Anti-Infective

Expand all

Apotex Corp. (Reverified 10/30/2019)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (25 vials) (NDC 60505-0759-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
2 g (25 vials) (NDC 60505-0760-05) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug
10 g (10 vials) (NDC 60505-0761-04) Product is temporarily discontinued Product manufactured by Hospira Discontinuation of the manufacture of the drug

Fresenius Kabi USA, LLC (Revised 11/12/2019)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g per vial; SDV; (NDC 63323-341-25) Backordered. Next release January 2020. Check wholesalers for inventory Shortage of an active ingredient
2 grams per vial; SDV; (NDC 63323-342-25) Backordered. Next release January 2020. Check wholesalers for inventory Shortage of an active ingredient

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 10/04/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1g vial (NDC 0143-9878-25) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the October - November 2019 timeframe. Product will be made available as it is released. Demand increase for the drug
2g vial (NDC 0143-9877-25) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the October 2019 timeframe. Product will be made available as it is released. Demand increase for the drug
10g vial (NDC 0143-9876-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing Product will be made available as it is released. Demand increase for the drug

Sagent Pharmaceuticals (Reverified 11/15/2019)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 g, package of 10 vials (NDC 25021-111-99) On backorder. Product continues to be manufactured with monthly releases. Estimated availability Nov-2019 Demand increase for the drug
1 g, package of 10 vials (NDC 25021-109-10) Available Manufacturing delay
2 g, package of 10 vials (NDC 25021-110-20) On allocation. Product continues to be manufactured with monthly releases. Estimated availability Nov-2019 Demand increase for the drug

WG Critical Care (Revised 11/04/2019)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 g (NDC 44567-245-25) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug
2 g (NDC 44567-246-25) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug
10 g (NDC 44567-247-10) On backorder. Next release December. Please check wholesalers for available inventory. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English